| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | R03CC12 |
| UNII: | Y1850G1OVC |
| InChI Key | ANZXOIAKUNOVQU-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H29N3O5 |
| Molecular Weight | 367.45 |
| AlogP | 2.23 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 91.34 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 26.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Beta-2 adrenergic receptor agonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2D
Cytochrome P450 2D6
|
- | 2000 | - | - | - | |
|
Enzyme
Hydrolase
|
- | 3-4.29 | - | 1.44 | 1.565 | |
|
Enzyme
Transferase
|
- | - | - | - | 20.81 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypertension, Pulmonary | 1 | D006976 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 81732-65-2 |
| ChEBI | 553827 |
| ChEMBL | CHEMBL521589 |
| DrugBank | DB01408 |
| DrugCentral | 285 |
| EPA CompTox | DTXSID5048550 |
| FDA SRS | Y1850G1OVC |
| Human Metabolome Database | HMDB0015478 |
| Guide to Pharmacology | 6601 |
| PharmGKB | PA164743113 |
| PubChem | 54766 |
| SureChEMBL | SCHEMBL4431 |